Journal
The oncologist
Publication Date
2-8-2023
Volume
28
Issue
2
First Page
e124
Last Page
e127
Document Type
Open Access Publication
DOI
10.1093/oncolo/oyac254
Rights and Permissions
Alexander Spira, Michael S Wertheim, Edward J Kim, Benjamin Tan, Heinz-Josef Lenz, Petros Nikolinakos, Patricia L Rich, Genevieve Jehl, Andreas Machl, Rena Ito, James L Gulley, Scott Kopetz, Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial, The Oncologist, Volume 28, Issue 2, February 2023, Pages e124–e127, https://doi.org/10.1093/oncolo/oyac254. https://academic.oup.com/oncolo/article/28/2/e124/6964580?login=true. © The Author(s) 2022. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Spira, Alexander; Wertheim, Michael S; Kim, Edward J; Tan, Benjamin; Lenz, Heinz-Josef; Nikolinakos, Petros; Rich, Patricia L; Jehl, Genevieve; Machl, Andreas; Ito, Rena; Gulley, James L; and Kopetz, Scott, "Bintrafusp alfa: A bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with pretreated colorectal cancer: Results from a phase I trial." The oncologist. 28, 2. e124 - e127. (2023).
https://digitalcommons.wustl.edu/oa_4/4674
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
